Literature DB >> 15695515

Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2.

David C West1, Chris G Rees, Laurence Duchesne, Susannah J Patey, Carla J Terry, Jeremy E Turnbull, Maryse Delehedde, Christian W Heegaard, Fabrice Allain, Christophe Vanpouille, Dina Ron, David G Fernig.   

Abstract

The hypothesis that neuropilin-1 (Npn-1) may interact with heparin-binding proteins other than vascular endothelial growth factor has been tested using an optical biosensor-based binding assay. The results show that fibroblast growth factor (FGF) 1, 2, 4, and 7, FGF receptor 1, hepatocyte growth factor/scatter factor (HGF/SF), FGF-binding protein, normal protease sensitive form of prion protein, antithrombin III, and Npn-1 itself are all able to interact with Npn-1 immobilized on the sensor surface. FGF-2, FGF-4, and HGF/SF are also shown to interact with Npn-1 in a solution assay. Moreover, these protein-protein interactions are dependent on the ionic strength of the medium and are inhibited by heparin, and the kinetics of binding of FGF-2, FGF-4 and HGF/SF to Npn-1 are characterized by fast association rate constants (270,000-1,600,000 m(-1) s(-1)). These results suggest that Npn-1 possesses a "heparin" mimetic site that is able to interact at least in part through ionic bonding with the heparin binding site on many of the proteins studied. Npn-1 was also found to potentiate the growth stimulatory activity of FGF-2 on human umbilical vein endothelial cells, indicating that Npn-1 may not just bind but also regulate the activity of heparin-binding proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695515     DOI: 10.1074/jbc.M410924200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  Secreted factors as synaptic organizers.

Authors:  Erin M Johnson-Venkatesh; Hisashi Umemori
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

Review 2.  Neuropilin Functions as an Essential Cell Surface Receptor.

Authors:  Hou-Fu Guo; Craig W Vander Kooi
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

3.  The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.

Authors:  Robert M Gemmill; Patrick Nasarre; Joyce Nair-Menon; Federico Cappuzzo; Lorenza Landi; Armida D'Incecco; Hidetaka Uramoto; Takeshi Yoshida; Eric B Haura; Kent Armeson; Harry A Drabkin
Journal:  Sci Signal       Date:  2017-01-17       Impact factor: 8.192

4.  Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.

Authors:  Guilong Zhang; Lukui Chen; Kouhong Sun; Ahsan Ali Khan; Jianghua Yan; Hongyi Liu; Ailin Lu; Ning Gu
Journal:  Tumour Biol       Date:  2016-08-01

Review 5.  Neuropilins and liver.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 6.  The role of the semaphorins in cancer.

Authors:  Gera Neufeld; Yelena Mumblat; Tatyana Smolkin; Shira Toledano; Inbal Nir-Zvi; Keren Ziv; Ofra Kessler
Journal:  Cell Adh Migr       Date:  2016-08-17       Impact factor: 3.405

7.  Neuropilin ligands in vascular and neuronal patterning.

Authors:  Alessandro Fantin; Charlotte H Maden; Christiana Ruhrberg
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

Review 8.  Semaphorins and their receptors in lung cancer.

Authors:  Vincent A Potiron; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Lett       Date:  2008-07-14       Impact factor: 8.679

Review 9.  Lymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axis.

Authors:  Matthew T Migliozzi; Patrick Mucka; Diane R Bielenberg
Journal:  Microvasc Res       Date:  2014-08-01       Impact factor: 3.514

Review 10.  Control of cellular motility by neuropilin-mediated physical interactions.

Authors:  Xiaobo Li; Matthew W Parker; Craig W Vander Kooi
Journal:  Biomol Concepts       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.